Pharmac not fit for purpose, overhaul needed
Photo:
An independent review has found Pharmac's current approach is not fit for purpose and has called for an overhaul of both strategy and culture.
Late last year, the board commissioned consultant Debbie Francis to review the drug-buying agency - amid criticism of some of its funding decisions.
The review's executive summary, released Tuesday, says major changes are required to meet the government's expectations - with staff at all levels expressing some sceptism over whether that was even possible.
It says Pharmac needs a clearer idea of its mission, and a set of measurable goals, as well as a complete reset of its operating model.
"The starting point for assessing Pharmac's performance is its statutory objective which is "to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided".
"While its statutory objective has remained unchanged since Pharmac was established, government and stakeholders expect the agency to evolve and be agile to meet the growing health needs of New Zealanders in a landscape in which new and more targeted drugs are constantly being developed and in demand. Specifically, the latest Letter of Ministerial Expectations for 2024/25 called for changes in organisational culture, roles and responsibilities, and methods and processes to meet these new challenges.
"Through the course of this review, it became clear that meeting these expectations will require a fundamental change in strategy and culture. Staff at all levels of the organisations expressed a degree of scepticism as to whether such a shift will be possible."
The board's chair Paula Bennett said she was confident people will soon see changes as Pharmac adopts a more outward-focused approach.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Spinoff
an hour ago
- The Spinoff
The Spinoff Essay: A bit of pain
'I'm lucky; I've had it for only five years or so.' David Hill on living with chronic pain. The Spinoff Essay showcases the best essayists in Aotearoa, on topics big and small. Made possible by the generous support of our members. I ache. I'm sore, nearly all the time. I'm one of the estimated 900,000 New Zealanders who suffer from chronic pain. Chronic or neuropathic pain is usually defined as pain that's lasted for more than three months. I'm lucky; I've had it for only five years or so. Multiple thousands of Kiwis have suffered for decades, or their entire life. More statistics. Over 40% of people in the UK are thought to suffer, at various times and to various degrees. (The US estimates almost 50%.) For over-75s in Britain, the figure lifts to 65%. About 80% of this is back and neck pain. In Aotearoa, a 2018 report from research group Sapere suggested that chronic pain costs our health system some $2 billion annually, plus another $15 billion in lost production and benefit costs. Utterly predictably (think housing, working conditions, $60 for a GP visit, $75 for a physio session), it affects lower socio-economic groups more. Oh, and (think trad Kiwi male stereotypes this time), women are more likely to report it than men. In my case, it's cervical spondylosis with foraminal narrowing and radiculopathy. I like to roll out the phrase so I can watch listeners' eyes cross as they wonder how much time I've got left. English translation: my neck is stuffed. Age, plus bad posture at the keyboard, means the cushioning discs between cervical vertebrae have worn thin. Bone spurs have formed. My mobility is limited; I get deep pain in the neck and between shoulder blades, plus intermittent giddiness. I've gone into detail because, like most sufferers – and I dislike that word – I usually don't say much about it. People with chronic pain get little sympathy. Who wants to hear about an ailment that goes on and on, especially when it usually comes with no bandages, slings, plaster, other visible signs of affliction? Like Chronic Fatigue Syndrome and Long Covid, it's easily seen, even by some health professionals, as self-pitying, even malingering. ' Whatever happened to 'pull yourself together'?' I heard one sceptic sniff, after an acquaintance had vented over his months of continuing hip and leg discomfort. It's the least telegenic of ailments; if we do appear on screen, we're usually caricatured as boring old whingers who need to snap out of it. ' It's all in your head,' is another common dismissal. True. Also stupid. Of course it's in the head, because that's where the brain's pain receptors are. We don't register any injury or discomfort till those receptors fire. Trouble is, if the pain continues for more than a few hours, your pre-frontal cortex starts assessing the sensation in terms of what it may mean long-term, and begins reinforcing the synapses associated with stress and discomfort. The brain's 'pain switch' gets stuck in the ON position, and your body becomes convinced of its distress. Neurologist William Davies notes that 'pain carves a path directly between the realms of mind and body'. It's called Control Sensitisation: just as Pavlov's dogs slobbered when a bell rang, almost any tug or tension for a chronic pain sufferer sends those brain receptors into power drive. It means that pain can become a habit, and like many unpleasant habits, it's hard to get rid of. A cycle of discomfort – sleep deprivation – stress – more discomfort and more stress can become established. Withdrawal and depression may follow, with the symbolic Black Dog liable to squat and crap on any of your days. So yes, it is all in the head, and it's utterly genuine. There have been some curious associated discoveries. Women's limbic system responds to pain more than men's, so women often experience greater emotional distress, while the fact that men's pre-frontal cortex is more affected means they may see the issue primarily as a problem to be analysed. And chronic pain may be exacerbated by apparently unassociated events; Brexit, the Covid pandemic, even the Trump presidency saw a rise in reported cases. You're right: the Orange Roughy can indeed become a pain in the arse. Bad news for the next few years. Chronic pain victims make unrewarding patients, even to sympathetic doctors – and not all are. Symptoms are frequently vague and diverse. We're the unwell who can sometimes seem well. Our GPs ask questions, refer us to specialists who ask more questions, at $2 per syllable, rule out nastier possibilities if you're lucky (and that is indeed a help), and usually intone variations on the theme of 'y ou'll have to live with it'. I sympathise with them, actually: as with Chronic Fatigue or Long Covid, we seldom give them the satisfaction of finding a specific cause. So chronic pain is a formless and often unresponsive condition. It can take a long time to get a diagnosis, and it seldom comes with any clear path of action. It can be treated, but seldom cured – whatever that last word may mean. What are the treatments? Painkillers, anti-inflammatories of course, though all of them, except perhaps paracetamol, come with potential side effects. A TROUP (Trends and Risks of Opioid Use for Pain) study in the US found that 22-26% of people prescribed opioids for non-malignant chronic pain ended up misusing their drugs. Distraction, meditation, exercise, diet, therapy, physio and chiropractic, the analytical and shared talk of Cognitive Behavioural Therapy are other courses of action – and action is an early step to taking some degree of control. The New Zealand Pain Society (you'll find them online) offers sensible, practical programmes and resources. Complex Chronic Illness Support, also online, can help as well. Our local hospital used to run chronic pain workshops, where physio, dietitian, psychiatrist, counsellor would reassure attendees that they weren't malingerers; it was a genuine ailment, and here was a list of things that might help. They're the only workshops I've ever attended where some participants stood up every 10 minutes and lay down in the aisle for a bit. They were enormously valuable for their collegial quality, finding that you weren't the only sufferer. They've been discontinued – more funding cuts at Whatu Ora, I gather. Alan Gordon in his book The Way Out estimated that in 2021, there were 1.2 billion chronic pain sufferers worldwide. The number is rising: we're living longer and hurting for longer periods. Other contributing factors include people expecting to be pain-lite and becoming more inclined to seek help when we're not, plus our living in an increasingly isolated society, where loneliness aggravates almost any condition. The outlook isn't great. The future, for me at any rate? Keep learning – in the most positive sense of the verb – to live with it. Take unexpected solace from the fact that on good days, the world can seem brighter and more rewarding than it did before my neck started to pack up. And wonder if assault with the nearest deadly weapon might be a pretty reasonable response to anyone who tells me that it's all in my head.
Otago Daily Times
2 hours ago
- Otago Daily Times
Public-private healthcare opportunities identified
A strategic report focused on the future of public health services in Otago Central Lakes has identified six potential opportunities for public-private collaboration. The Otago Central Lakes strategic health report was sent to Health Minister Simeon Brown in February by the steering group, which was comprised of Southland MP Joseph Mooney, Health New Zealand, the Central Otago and Queenstown Lakes District Councils, rural health providers, iwi, including kaupapa Māori health providers, Act MP Todd Stephenson and Waitaki MP Miles Anderson. Mr Mooney said the group's objective was to "expedite planning and investment in health services and infrastructure in Otago Central Lakes" — Central Otago District Mayor Tamah Alley said 70% of New Zealanders who lived two or more hours from a hospital resided in that region. The report said health service improvements were required to meet the current and future populations' needs. On a peak day, the district's combined population, which included visitors, was 168,000 — expected to nearly double by 2054, it said. "There is a reputational risk to all of Aotearoa New Zealand if adequate healthcare services are unavailable to deal with international visitor illness or injury." The report identified opportunities to increase public health services by partnering with the private sector, but Mr Anderson said the project was "not asking for public funds". The "early stage" public-private partnerships included in the report, which were "ready for collaboration", are: • The Southern Lakes Public Hospital — the location of which is to be determined — which is a proposed privately financed facility with full public hospital services and future capacity to become a regional hospital. • Lakeview Te Taumata Clinic (Queenstown), a private surgical hospital expected to open in 2027, with opportunities for maternity care and workforce development. • Integrated Care Hub (Wānaka), a planned day surgery with potential space for publicly funded after-hours services. • Wānaka Health Precinct, a private surgical hospital designed with capacity to integrate public services. • Aged-care facilities (Clyde), which are under construction, have the potential to expand into a full suite of publicly funded services for older people in Central Otago. • Securing land and investors in Central Otago for future public health infrastructure, based on the outcomes of the other projects. Additionally, the trust was exploring "innovative mobile modular units" which could be used as consultation rooms, clinics or staff accommodation and wanted to find land to host them in areas where they were needed, the report said. The $2 million funding was required to "complete the groundwork" for community consultation, clinical design and planning process, and technical assessments and detailed business cases Health New Zealand could work with — it already had $400,000 seed funding, it said. Subject to Mr Brown's support, a working group would be established to work with Health New Zealand to progress the proposed solutions — community engagement and consultation would follow.
1News
9 hours ago
- 1News
Call to rethink tax on KiwiSaver
KiwiSaver members could be significantly better off if New Zealand adopted a taxation model similar to Australia's, an economist says. Simplicity chief economist Shamubeel Eaqub ran some numbers modelling a system similar to Australia's, where contributions and returns are taxed at 15%. In New Zealand, full tax is paid on income contributed to KiwiSaver, and returns in PIE schemes taxed at an investor's prescribed investor rate up to 28%. Eaqub said an "average" KiwiSaver investor starting now could end up $60,000 better off in nominal terms at retirement on a model similar to Australia's. If tax was not paid on contributions or returns, they could be about $1 million better off - and if only taxes on returns were removed the gain would be about $300,000. "In Australia, the context is there's some conversation about whether the tax breaks are too generous for richer people. It's not that it's perfect but the point is in other countries it's heavily incentivised for people to save in their private pension." ADVERTISEMENT But it was not in New Zealand. Kirk Hope, chief executive of the Financial Services Council, which represents KiwiSaver providers, said the Australian model was different because that country has a means-tested pension. "The tax break that occurs in New Zealand occurs when you retire, when you get national super... that is the equivalent of about $500,000. So I think it's hard to do a comparative analysis without acknowledging that there are significant differences between the schemes and what they are trying to achieve." Winter's here, supermarket spying, and TikTok's new feature. (Source: 1News) But he said if the tax on savings for New Zealanders was reduced it would give future governments more "fiscal options" in relation to superannuation. He said New Zealand previously had a system that was EET — or exempt, exempt, taxed, where contributions were tax-exempt, exempt from tax within the scheme and then fully taxed when withdrawn. The Tax Working Group in 2018 acknowledged that the change from that system had potentially created incentives for New Zealanders to direct savings into investments like houses instead. ADVERTISEMENT Hope said it would be expensive to adjust back to EET but there could be other changes that would be more affordable. The tax working group estimated that ignoring behavioural changes, it would cost $200m to $300m a year to move to a system where returns and withdrawals were not taxed, and $2.5b a year to move to an EET system. "The higher initial cost for an EET regime arises from the fact that there will be a substantial deferral period before significant amounts are withdrawn from the scheme, and thus taxed under the third 't'. Although these are very different initial costs, the costs will be the same in the long run on a net present value basis." Hope said providing different forms of tax incentives would be beneficial for savers. He said removing or reducing the employer contribution tax would be particularly useful for low-income people. Kernel Wealth founder Dean Anderson said New Zealand was one of the few countries operating a TTE — taxed contributions, taxed returns and exempt withdrawal — model. "Our future savings would be much better off under an EET approach, where we don't pay tax on the way in but on the way out. ADVERTISEMENT "With low savings rates in NZ, the government should be exploring everything in its powers to grow savings rates, which benefits NZ and Kiwis over the long term. "But it's not a surprise. The recent meek KiwiSaver policy announcement did all the hard work to announce a positive gradual increase to KiwiSaver contributions, yet they fell short by announcing a three-year policy rather than outlining a decade plus long policy of incremental KiwiSaver increases." Ana-Marie Lockyer, chief executive at Pie Funds, said KiwiSaver members were at a disadvantage compared to Australians because there was no upfront tax incentive or concession as in Australia to encourage them to contribute more. "Maybe consideration of a mid-tier flat tax rate on savings up to a certain amount would encourage savings." She said employer contributions were also taxed so investors lost the benefits of compounding, and investors paid tax on bonds and deemed dividends on global equities so they were effectively paying a capital gains tax. "So contrary to the government's stated goal of helping New Zealanders' grow their KiwiSaver balances, these factors mean New Zealanders have less incentives to make voluntary contributions and pay more tax on investment earnings, resulting in smaller balances at retirement relative to our Australian friends."
